The roles of neutrophil-derived myeloperoxidase (MPO) in diseases: the new progress

W Lin, H Chen, X Chen, C Guo - Antioxidants, 2024 - mdpi.com
Myeloperoxidase (MPO) is a heme-containing peroxidase, mainly expressed in neutrophils
and, to a lesser extent, in monocytes. MPO is known to have a broad bactericidal ability via …

Neutrophils as regulators of cardiovascular inflammation

C Silvestre-Roig, Q Braster, A Ortega-Gomez… - Nature Reviews …, 2020 - nature.com
Neutrophils have traditionally been viewed as bystanders or biomarkers of cardiovascular
disease. However, studies in the past decade have demonstrated the important functions of …

Targeting cardiovascular inflammation: next steps in clinical translation

PR Lawler, DL Bhatt, LC Godoy… - European heart …, 2021 - academic.oup.com
Systemic vascular inflammation plays multiple maladaptive roles which contribute to the
progression and destabilization of atherosclerotic cardiovascular disease (ASCVD). These …

Myeloperoxidase–A bridge linking inflammation and oxidative stress with cardiovascular disease

G Ndrepepa - Clinica chimica acta, 2019 - Elsevier
Myeloperoxidase (MPO) is a member of the superfamily of heme peroxidases that is mainly
expressed in neutrophils and monocytes. MPO-derived reactive species play a key role in …

[HTML][HTML] Myeloperoxidase: regulation of neutrophil function and target for therapy

SA Rizo-Téllez, M Sekheri, JG Filep - Antioxidants, 2022 - mdpi.com
Neutrophils, the most abundant white blood cells in humans, are critical for host defense
against invading pathogens. Equipped with an array of antimicrobial molecules, neutrophils …

[HTML][HTML] Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement

ND Wong, MJ Budoff, K Ferdinand, IM Graham… - American Journal of …, 2022 - Elsevier
Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity
both in generally healthy persons and in those with known ASCVD. The foundation of …

A high-dimensional microfluidic approach for selection of aptamers with programmable binding affinities

D Chang, Z Wang, CD Flynn, A Mahmud, M Labib… - Nature …, 2023 - nature.com
Aptamers are being applied as affinity reagents in analytical applications owing to their high
stability, compact size and amenability to chemical modification. Generating aptamers with …

The role of myeloperoxidase in biomolecule modification, chronic inflammation, and disease

MJ Davies, CL Hawkins - Antioxidants & redox signaling, 2020 - liebertpub.com
Significance: The release of myeloperoxidase (MPO) by activated leukocytes is critical in
innate immune responses. MPO produces hypochlorous acid (HOCl) and other strong …

[HTML][HTML] Myeloperoxidase as an active disease biomarker: recent biochemical and pathological perspectives

AA Khan, MA Alsahli, AH Rahmani - Medical sciences, 2018 - mdpi.com
Myeloperoxidase (MPO) belongs to the family of heme-containing peroxidases, produced
mostly from polymorphonuclear neutrophils. The active enzyme (150 kDa) is the product of …

[HTML][HTML] Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage

CL Hawkins, MJ Davies - Free Radical Biology and Medicine, 2021 - Elsevier
The heme peroxidase family generates a battery of oxidants both for synthetic purposes, and
in the innate immune defence against pathogens. Myeloperoxidase (MPO) is the most …